Shareholder approval for the name change was given on that day and it can take 2 to 4 weeks for FINRA to post system changes.
I am kinda looking for the 27th as a ballpark, although it could happen a little sooner or a little later.
We are also looking forward to seeing Oncolix add to their BOD.
That could happen at any point moving forward.
I think there is a possibility of Oncolix accredited investor and former CEO of GlaxoSmithKline NYSE: GSK, Ernest Mario being appointed to the BOD (or a representative of his family trust.)
While I don't think he would meet the criteria of being an independent member, it would be a logical choice.
It would be nice to see some Rutgers University staff and alumni take an interest in his endeavors since they named the School of Pharmacy after him.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.